Lineage Cell Therapeutics Inc. (LCTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Lineage Cell Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Lineage Cell Therapeutics Inc. (LCTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $260M. It trades at $1.04, up 0.97% today. 4 analysts' average target of $6.25 implies +501.0% from today's price. Kronos AI's 30-day forecast is +5.2% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.25 |
| Low – high | $3.00 – $9.00 |
| Analysts | 4 |
| Upside to average | +501.0% |
Kronos AI 30-day forecast
| Expected close | $1.08 (+5.2%) |
| Likely range | −3.0% … +8.0% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator